Litcius/Paper detail

Cancer therapy resistance from a spatial‐omics perspective

Yinghao Zhang, Cheng Yang, Xi Chen, Liang Wu, Zhiyuan Yuan, Fan Zhang, Bin‐Zhi Qian

2025Clinical and Translational Medicine13 citationsDOIOpen Access PDF

Abstract

Cancer therapy resistance (CTR) remains a significant challenge in oncology. Traditional methods like imaging, liquid biopsies and conventional omics analyses provide valuable insights, but lack the spatial resolution to fully characterise heterogeneity of tumour and the tumour microenvironment (TME). Recent advancements in spatial omics technologies offer unprecedented insights into the spatial organisation of tumours and TME. In this review, we summarise current methodologies for CTR research and highlight how spatial omics technologies and computational methods are revolutionising our understanding of CTR mechanisms. We also summarise recent studies leveraging spatial omics to uncover novel insights into CTR across various cancer types and therapies and discuss future opportunities.

Topics & Concepts

OmicsPerspective (graphical)CancerData scienceComputational biologyMedicineComputer scienceBioinformaticsBiologyArtificial intelligenceInternal medicineSingle-cell and spatial transcriptomicsCancer Genomics and DiagnosticsCell Image Analysis Techniques
Cancer therapy resistance from a spatial‐omics perspective | Litcius